Johnson & Johnson (BMV:JNJ)

Market Cap	7.80T
Revenue (ttm)	1.71T
Net Income (ttm)	427.13B
Shares Out	n/a
EPS (ttm)	175.93
PE Ratio	18.26
Forward PE	16.12
Dividend	99.57 (3.07%)
Ex-Dividend Date	Aug 26, 2025

Volume	13,991
Average Volume	3,106
Open	3,230.00
Previous Close	3,250.01
Day's Range	3,230.00 - 3,255.00
52-Week Range	2,836.00 - 3,535.00
Beta	0.39
RSI	46.04
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD